Upon completion of this seminar, the primary care provider will be able to:

1. 1. Describe how to effectively educate your local community on the health benefits of proper nutrition, exercise, and better personal health choices
2. 2. Demonstrate an understanding of the behavioral indicators that impact patient compliance.
3. 3. Apply the clinical techniques that increase compliance, resulting in improved patient care.
4. 4. Develop individual elements to a successful wellness program based on medical specialty, strengths, and the needs of the local community.
5. 5. Identify a process that has been used to accomplish specific community healthcare goals.
6. 6. Evaluate the qualifications of support staff to maximize a successful wellness program.
7. 7. Create synergistic partnerships to support and sustain change.
8. 8. Identify the limitations of conventional allopathic practice in addition to the breadth and therapeutic potency of an integrated approach, including: hormone analysis and balancing for maximum therapeutic potency in service and devotion to the patient.
9. 9. Apply a graduated approach to practice transition by identifying the balance between hormone replacement and mental focus, while maintaining the conventional portion of your practice.
10. 10. Identify the financial factors which are impeding physicians from delivering maximally efficient and therapeutic care and how to deal with them.
11. 11. Discuss current literature on the role of thyroid, adrenal, and sex hormones as they pertain to conditions thought to be “psychiatric” or “mental health” areas of concern.
12. 12. Demonstrate the concept of “stabilizing the biological platform” in mental health. Learn how to stop blaming or stigmatizing the patient when depression and mental disorders do not seem to be responding to conventional treatment.
13. 13. Demonstrate an understanding of aggressive psychopharmacology, as well as dealing with the need for use of emergency psychotropics in conventional medical practice.
14. 14. Understand, quickly grasp, and expertly diagnose and treat with straightforward psychotropics, as needed.
15. 15. Evaluate and become proficient in the medical literature that supports biologically identical hormone replacement in contrast to chemically altered hormones and realize that “all hormones are not the same” as demonstrated in the literature.
16. 16. Describe the diagnosis and treatment of adult onset growth hormone deficiency.
17. 17. Identify the techniques used to administer acceptable levels of human growth hormone (HGH).
18. 18. Examine and discuss possible side effects of HGH and how to properly adjust dosing.
19. 19. Distinguish the different types of secretagogues and evaluate their effectiveness as an alternative to HGH therapy.
20. 20. Implement therapeutic management of andropause based on studies reported in prestigious medical journals.
21. 21. Identify the types, doses and methods to administer testosterone to men and women.
22. 22. Determine the uses of testosterone for men and women, including complications, precautions, side effects and monitoring.
23. 23. Discuss the uses of Finasteride, Dutasteride, Anastrozole in the management of testosterone administration.
24. 24. Identify the uses of melatonin including correct dosing and monitoring.
25. 25. Apply strategies for the effective uses of DHEA and pregnenolone including correct dosing and monitoring.
26. 26. Evaluate new evidence that contradicts the WHI Study on estrogen treatment in women.
27. 27. Demonstrate an understanding of the health benefits of estrogen and progesterone in contrast to the health detriments of synthetic estrogen and progestin.
28. 28. Describe the types, doses and methods used to administer estrogen and progesterone.
29. 29. Discuss recent literature, questions and answers that demonstrate the beneficial effects of hormones in improved function and healing and a better quality of life.
30. 30. Explain current concepts of thyroid replacement and compare and contrast different types of thyroid as supported in the medical literature.
31. 31. Recognize various methods of testing for thyroid deficiencies and what labs and approaches are best.
32. 32. Discuss and analyze interesting cases in bio identical hormone replacement therapy.
33. 33. Recognize the difference between “normal levels” and “optimal levels” of hormones and the benefits or detriments as demonstrated by current medical studies.
34. 34. Implement best clinical practices in diagnosing, prescribing, monitoring and adjusting of BHRT for improved function and quality of life.
35. 35. Develop and apply business management principles to set up a preventive medicine practice.
36. 36. Analyze and review treatment protocols in case management and troubleshooting techniques used in BHRT.
37. 37. Describe how to write prescriptions for compounded hormones to pharmacies, and how different formulations can affect absorption, efficacy and side effects.
38. 38. Correct any inaccurate or inappropriately prescribed hormone therapy to conform to scientific standards as seen in medical literature.
39. 39. Implement current strategies into your practice to improve the level of care and patient compliance in the treatment of adult hormone deficiencies.
40. 40. Assure that prescribed hormones meet standards of care based on attaining adequate serum levels and symptom improvement.

Upon completion of this seminar, the primary care provider will be able to:

1. 1. Identify the declining micronutrient content of the typical American diet: Why we are over-fed but undernourished?
2. 2. Demonstrate an understanding of the risks for significant nutrient depletion associated with common prescription and over-the-counter medications
3. 3. Evaluate which common nutritional supplements have side effects.
4. 4. Determine how to sort through supplement safety and efficacy issues.
5. 5. Demonstrate the preventive health benefits of maintaining good intestinal flora.
6. 6. Describe the various clinical disorders that are caused by a lack of probiotics and how to treat them.
7. 7. Determine the structure and function of human telomeres and telomerase.
8. 8. Discuss the literature demonstrating the strong association between telomere length and aging/chronic disease risk.
9. 9. Examine clinically available methods for telomere length measurement (qPCR, Flow-FISH, and STELA for short telomeres).
10. 10. Evaluate the currently available ways to slow telomere shortening through diet, exercise, stress reduction, antioxidants, bHRT, and small-molecule telomerase activation.
11. 11. Outline key elements in HRT presented in Part One: Mastering the Protocols for Optimization of Hormone Replacement Therapy.
12. 12. Identify important issues in the relationship between hormones and cancer: cause, provocation or protection?
13. 13. Outline problem-solving techniques for difficult cases presenting with multiple disease processes and the potential benefits of hormones.
14. 14. Discuss literature citing new indications, risks, benefits and complications of estrogen, progesterone and testosterone therapy.
15. 15. Determine advanced treatment modalities and dosing strategies for estrogen and progesterone, including new and specific approaches to these therapies.
16. 16. Describe important aspects of the WHI findings: identify the experts that refute this study, and other factors not included in the trials that would change the conclusions.
17. 17. Determine advanced treatment modalities, including new and specific approaches to HGH, thyroid and testosterone in age management and disease prevention.
18. 18. Discuss over 40 articles that demonstrate thyroid replacement does not cause osteoporosis, even in TSH suppressive doses.
19. 19. Identify various new therapies for erectile/sexual dysfunction in men and women.
20. 20. Evaluate the epidemiology of cardiovascular disease and diabetes and the various treatment strategies as they pertain to medication, diet, exercise, lifestyle change and nutritional supplements.
21. 21. Explore the role of omega 3 fatty acids, antioxidants and glucose and their influence on insulin, inflammation, disease progression and atherosclerosis.
22. 22. Describe the strategies for using the new cardiovascular risk markers, inflammation markers, new lipid parameters and how to make sense of all the new lipid fractionation components.
23. 23. Identify the roles of niacin and EFA in diabetes and atherosclerosis.
24. 24. Identify rational approaches to vitamins and supplements with a review of the medical literature supporting their use in wellness as well as citing any harmful effects and interactions.
25. 25. Determine current screening methods and management strategies of the most common pre-menopausal hormone disorder, Polycystic Ovary Syndrome (PCOS).
26. 26. Implement diagnostic and treatment strategies for PCOS.
27. 27. Apply diagnostic and treatment strategies for hirsutism and hair loss.
28. 28. Implement strategies for treating osteoporosis using hormone replacement therapy.
29. 29. Discuss interesting cases in bio identical hormone replacement therapy.
30. 30. Identify current indications, risks and benefits of using cortisol for the treatment of chronic fatigue.
31. 31. Determine rational approaches for the evaluation of fatigue with emphasis on cellular hypofunction as it pertains to thyroid hormone.
32. 32. Describe, based on the literature, when to use oral vs. saliva testing.
33. 33. Utilize the knowledge gained to improve patient outcomes in BHRT.

Upon completion of this seminar, the primary care provider will be able to:

1. 1. Outline key elements in age management presented in Part Two: Mastering the Protocols for Optimization of Hormone Replacement Therapy, per relevant literature and case studies.
2. 2. Discuss the most current literature for bio identical hormone replacement therapy (BHRT), Human Growth Hormone (HGH), thyroid, testosterone, pregnenolone, Dehydroepiandrosterone (DHEA), melatonin, estrogen and progesterone.
3. 3. Determine the risks and benefits of transdermal estrogen vs. oral estrogen.
4. 4. Discuss new research demonstrating estrogen’s protective effects in men as well as lack of any harm.
5. 5. Examine current recommendations for hormone replacement therapy by the North American Menopause Society (NAMS) and American College of Obstetricians and Gynecologists (ACOG).
6. 6. Describe rational approaches to the use of hormones in cancer patients, including recent studies that demonstrate progesterone’s protection against breast cancer and the adverse effects of progestins.
7. 7. Discuss new therapies for prostate cancer as well as better diagnostic sensitivity and specificity of MRI-S scan.
8. 8. Determine current management strategies for preventing loss of pregnancy in Polysystic Ovary Syndrome (PCOS), as well as preventing and treating postpartum depression.
9. 9. Describe the clinical evaluation including laboratory analysis and treatment of Vitamin D deficiency.
10. 10. Examine literature reviews as to what level of Vitamin D protects against cancer, CAD, osteoporosis, dementia, type II DM and AMD.
11. 11. Discuss the pathophysiology of vaginal atrophy and the use of rings, tabs, troches and creams.
12. 12. Discuss the importance of sex hormone binding globulin (SHBG) in men and women and why it is most predictive of CAD, MS and cancer.
13. 13. Describe the data demonstrating that androgen suppression therapy, as well as estrogen deprivation, is associated with poor survival in men in comparison with placebo.
14. 14. Outline advanced treatment protocols for over 100 clinical cases based on clinical presentation, history and complications.
15. 15. Discuss the inverse relationship of estrogen and prostate cancer.
16. 16. Develop an understanding of treatment rationale through case presentations.
17. 17. Appreciate the lack of efficacy of estriol in spite of purported benefits.
18. 18. Review the recent recommendations from Family Practice Recertification on the use of IGF-1 instead of the ITT to diagnosis GH deficiency.
19. 19. Discuss recent studies demonstrating IGFBP-3 induces apoptosis in prostate cancer and breast cancer.
20. 20. Review the antiproliferative, oncostatic, immuno-stimulatory and thrombopoetic effects of melatonin.
21. 21. Describe the difference in clotting between Premarin®, Provera® and micronized progesterone.
22. 22. Examine data proving that oral progesterone decreases clotting risk and inflammation as opposed to Provera® that increases these risks.
23. 23. Appreciate the data demonstrating that only certain types of estrogen reduce fatty acid synthesis thereby resulting in a protection against atherosclerosis.
24. 24. Demonstrate an understanding of the importance of maintaining low levels of aldosterone.
25. 25. Demonstrate an understanding of the importance of body weight in determining which type of HRT to prescribe.
26. 26. Describe the data demonstrating that testosterone both decreases and increases CAD in women and learn to decipher the correct approach.
27. 27. Identify the two mechanisms by which estrogen treats and protects against prostate cancer.